By the end of this lesson, learners will be able to explain the fundamental principles of pharmacokinetics, including absorption, distribution, metabolism, and excretion of drugs, and apply these concepts to predict drug behavior, therapeutic effects, and potential toxicity in the body.

By the end of this lesson, learners will be able to explain the organization and function of the sympathetic and parasympathetic divisions of the autonomic nervous system, describe the neurotransmitters and receptors involved, and predict physiological responses to autonomic stimulation in different organ systems.

By the end of this lesson, learners will be able to describe the pharmacology of cholinergic agents, including muscarinic and nicotinic receptor agonists and antagonists, explain their mechanisms of action, and predict the physiological and clinical effects of modulating cholinergic signaling in the peripheral and central nervous systems.

By the end of this lesson, learners will be able to explain the pharmacology of adrenergic agents, including alpha- and beta-adrenergic receptor agonists and antagonists, describe their mechanisms of action, and predict the physiological and clinical effects of modulating adrenergic signaling in various organ systems.

By the end of this lesson, learners will be able to explain the autonomic regulation of ocular function, classify ophthalmic drugs based on their autonomic actions, and apply this knowledge to understand the therapeutic uses and adverse effects of drugs used in conditions such as glaucoma, uveitis, and refractive disorders.

By the end of this lesson, learners will be able to classify diuretics, describe their mechanisms of action at different sites of the nephron, compare their therapeutic uses, and identify key adverse effects and clinical considerations in patient management.

By the end of this lesson, learners will be able to explain the pharmacological classes of antihypertensive drugs, their mechanisms of action, therapeutic effects, and potential adverse effects, and apply this knowledge to understand their use in managing hypertension.

By the end of this module (M06.09 – Heart Failure Drugs), learners should be able to classify major drug classes used in heart failure, explain their mechanisms of action in reducing preload, afterload, and neurohormonal activation, identify key indications and adverse effects, and differentiate pharmacologic management of acute and chronic heart failure.

By the end of this module, learners should be able to classify antiarrhythmic drugs based on the Vaughan–Williams classification and explain their mechanisms of action, therapeutic uses, and major adverse effects in the management of cardiac arrhythmias.

By the end of this module, learners should be able to describe the pathophysiology of myocardial ischemia and explain the mechanisms of action, therapeutic uses, and major adverse effects of antianginal drug classes including nitrates, beta blockers, calcium channel blockers, and other agents used in the management of angina pectoris.

Learners should classify antihyperlipidemic drug classes, explain their mechanisms, effects on LDL, HDL, and triglycerides, identify clinical uses and adverse effects, and apply pharmacologic principles to guide appropriate therapy selection in dyslipidemia management.

The M06 Quizzes: Pharmacology series aims to assess students’ comprehension of pharmacological concepts and applications across various therapeutic areas. These quizzes cover topics such as drug classification, mechanisms of action, clinical applications, adverse effects, and drug interactions, providing a comprehensive evaluation of pharmacological knowledge essential for clinical practice.